Treatment of drug-resistant tuberculosis in patients with HIV-1 infection

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 2, 2018, Pages

  Arentz, Matthew ^a   Horne, David J ^a   Walson, Judd L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 85041958388     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009473.pub2     Document Type: Article

References (7)

1. Cain KP, Kanara N, Laserson KF, Vannarith C, Sameourn K, Samnang K, et al. The epidemiology of HIV-associated tuberculosis in rural Cambodia. Int J Tuberc Lung Dis 2007;11:1008-13.
2. Caminero JA. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006;10:829-37.
3. Dye C, Williams BG, Espinal MA, Raviglione MC. Erasing the world's slow stain: strategies to beat multi-drug resistant tuberculosis. Science 2002;295:2042-6.
4. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-80.
5. Nathanson E, Gupta R, Huamani P, et al. Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. Int J Tuberc Lung Dis 2004;8:1382-4.
6. Rajeswaran G, Becker GL, Michailidis C, Pozniak AL, Padley SP. The radiology of IRIS (immune reconstitution inflammatory syndrome) in patients with mycobacterial tuberculosis and HIV co-infection: Appearances in 11 patients. Clin Radiol 2006;61:833-43.
7. Global tuberculosis control: epidemiology, strategy, financing: WHO report. WHO reports 2009.